Condition: Acute Myelogenous Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndromes · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to find out whether Cord Blood Transplantation/CBT as the first or second transplant is an effective treatment for children and young adults with blood cancer.
This description comes directly from the study's public registry record.
Andromachi Scaradavou, MD · 833-MSK-KIDS · ScaradaA@mskcc.org
Jaap Jan Boelens, MD, PhD · 833-MSK-KIDS · boelensj@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07566377